CVRx Investor Relations Material
Latest events
Q4 2024
CVRx
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from CVRx Inc
Access all reports
CVRx develops and commercializes neuromodulation solutions for patients with heart failure. CVRx's first product, Barostim, is a investigational device that delivers low-energy electrical stimulation to the left ventricle through cardiac leads inserted into veins that leave the left ventricle.
Key slides for CVRx Inc
43rd Annual J.P. Morgan Healthcare Conference 2025
CVRx Inc
43rd Annual J.P. Morgan Healthcare Conference 2025
CVRx Inc
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
CVRX
Country
🇺🇸 United States